ArticleTobacco control2005
Impact of UK policy initiatives on use of medicines to aid smoking cessation.
Article in Tobacco control, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed.
- Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.The Lancet. Respiratory medicine · 2015Trial
- Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2010Trial
- Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.Annals of internal medicine · 2010Trial
- Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.Thorax · 2008Trial
- Reasons for not using smoking cessation aids.BMC public health · 2008Trial
- Individual and Conjoint Factors Associated With Beliefs About the Harmfulness of Nicotine Replacement Therapies Relative to Combustible Cigarettes Among People Who Smoke: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- [Fourteen years of tobacco control law in Spain. Current situation and proposals].Atencion primaria · 2020Article
- Development and Validation of an Evaluation Tool to Measure the Effectiveness of a Smoking Cessation Training among Healthcare Providers in Malaysia: The Providers' Smoking Cessation Training Evaluation (ProSCiTE).International journal of environmental research and public health · 2019Article
- Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group.Tobacco control · 2019Review
- Evaluating the Impact of Eliminating Copayments for Tobacco Cessation Pharmacotherapy.Medical care · 2018Article
- Public health impact of a novel smoking cessation outreach program in Ontario, Canada.BMC public health · 2018Article
- Effects of Prefrontal Transcranial Direct Current Stimulation and Motivation to Quit in Tobacco Smokers: A Randomized, Sham Controlled, Double-Blind Trial.Frontiers in pharmacology · 2018Article
- Quitting activity and use of cessation assistance reported by smokers in eight European countries: Findings from the EUREST-PLUS ITC Europe Surveys.Tobacco induced diseases · 2018Article
- Prevalence and Impact of Long-term Use of Nicotine Replacement Therapy in UK Stop-Smoking Services: Findings From the ELONS Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017Article
- Availability, Sales, and Affordability of Tobacco Cessation Medicines in Kerala, India.Circulation. Cardiovascular quality and outcomes · 2017Article
- E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys.BMJ (Clinical research ed.) · 2017Article
- The impact of TV mass media campaigns on calls to a National Quitline and the use of prescribed nicotine replacement therapy: a structural vector autoregression analysis.Addiction (Abingdon, England) · 2017Article
- New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?CNS drugs · 2016Review
- Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.Tobacco control · 2016Article
- Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis.Tobacco induced diseases · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextIncreasing the use of effective smoking cessation aids could in principle have a substantial public health impact. The UK government has undertaken several major policy initiatives to try to increase usage of smoking cessation medicines. It is important to evaluate what effect, if any, these have had to inform future policy in the UK and internationally.
objectiveThis study used sales data to examine the impact of government initiatives to increase access to smoking cessation medicines.
designInformation about prescription and non-prescription sales (1999-2002) was obtained. Estimates of utilisation were compared with findings from the Office of National Statistics (ONS) omnibus surveys. The effects of policy initiatives (making the medicines reimbursable and making them available on general sale outside pharmacies) were assessed by means of time series analysis. In addition a new nicotine replacement therapy (NRT) product (a nicotine lozenge) was launched and the effect of this on total utilisation was assessed.
resultsMaking bupropion, and subsequently nicotine replacement therapy (NRT), reimbursable had a major impact in medication usage; the estimated increase in each case was more than 80 000 "treatment weeks" purchased per month. In addition, introduction of a nicotine lozenge increased total utilisation and did not detract from usage of other medicines. According to both the sales and the survey data, the proportion of smokers using medicines to aid smoking cessation more than doubled from 8-9% in 1999 to 17% in 2002. The ONS surveys showed no increase in the proportions of smokers making quit attempts and so the effects were solely on the proportions of quit attempts that were aided by medication.
conclusionsIn the UK, making smoking cessation medicines reimbursable led to a large increase in utilisation. While the effect on smoking prevalence would be too small to be detected in national surveys it could have a substantial public health impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.